Staging urinary bladder cancer after transurethral biopsy: Value of fast dynamic contrast-enhanced MR imaging

Radiology

Volumn 201, Issue 1, 1996, Pages 185-193

  Barentsz, Jelle O ^a   Jager, Gerrit J ^a   Van Vierzen, Peter B J ^a   Witjes, J Alfred ^a   Strijk, Simon P ^a   Peters, Herman ^a   Karssemeijer, Nico ^a   Ruijs, Sjef H J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bladder neoplasms; Bladder neoplasms, MR; Bladder neoplasms, staging; Gadolinium; Glucagon; Magnetic resonance (MR); treatment planning

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CANCER; CANCER STAGING; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0029788619     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.201.1.8816542     Document Type: Article

References (28)

1. Jewett HJ. Cancer of the bladder. Cancer 1973; 32:1072-1075.
2. Fisher MR, Hricak H, Tanagho EA. Urinary bladder MR imaging. II. Neoplasm. Radiology 1985; 157:471-477.
3. Amendola MA, Glaser GM, Grossman HB, Aisen AM, Francis JR. Staging of bladder carcinoma: MRI-CT-surgical correlation. AJR 1986; 146:1179-1183.
4. Bryan PJ, Butler HE, LiPuma JP, Resnik MI, Kursh ED. CT and MR imaging in staging bladder neoplasms. J Comput Assist Tomogr 1987; 11:96-101.
5. Rholl KS, Lee JKT, Heiken JP, Ling D, Glazer HS. Primary bladder carcinoma: evaluation with MR imaging. Radiology 1987; 163:117-123.
6. Buy JN, Moss AA, Guinet C, et al. MR staging of bladder carcinoma: correlation with pathologic findings. Radiology 1988; 169:695-700.
7. Husband JE, Olliff JF, Williams MP, Heron CW, Cherryman GR. Bladder cancer: staging with CT and MR imaging. Radiology 1989; 173:435-440.
8. Barentsz JO, Debruyne FMJ, Ruijs SHJ. Magnetic resonance imaging of carcinoma of the urinary bladder. Boston, Mass: Kluwer, 1990.
9. Tachibana M, Baba S, Deguchi N, et al. Efficacy of gadolinium-diethylenetriamine-pentaacetic acid-enhanced magnetic resonance imaging for differentiation between superficial and muscle-invasive tumor of the bladder: a comparative study with computerized tomography and transurethral ultrasonography. J Urol 1991; 145: 1169-1173.
10. Barentsz JO, Ruijs SHJ, Strijk SP. The role of MR imaging in carcinoma of the urinary bladder. AJR 1993; 160:937-947.
11. Doringer E, Joos H, Forstner R, Schmoller H. MRI of bladder carcinoma: tumor staging and gadolinium contrast behaviour. ROFO 1991; 154:357-363.
12. Sohn M, Neuerburg JM, Teufl F, Bohndorf K. Gadolinium-enhanced magnetic resonance imaging in the staging of urinary bladder neoplasms. Urol Int 1990; 45:142-147.
13. Nicolas V, Spielmann R, Maas R, et al. The diagnostic value of MRI and gadolinium-DTPA compared with CT for the diagnosis of bladder tumors. ROFO 1990; 153:197-203.
14. Sparenberg A, Hamm B, Hammerer P, Samberger V, Wolf KJ. The diagnosis of bladder carcinomas by NMR tomography: an improvement with Gd-DTPA? ROFO 1991; 155:117-122.
15. Kim B, Semelka RC, Ascher SM, Chalpin DB, Carrol PR, Hricak H. Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging. Radiology 1994; 193:239-245.
16. Neuerburg JM, Bohndorf K, Sohn M, Teufl F, Guenther RW, Daus HJ. Urinary bladder neoplasms: evaluation with contrast-enhanced MR imaging. Radiology 1989; 172:739-743.
17. McGinnis DE, Rifkin MD, Gornella LG. New MR imaging techniques for staging bladder cancer: endorectal coil and gadolinium image enhancement (abstr). J Urol 1992; 147:402A.
18. Boetes C, Barentsz JO, Mus RD, et al. MR characterization of suspicious breast lesions with gadolinium-enhanced TurboFLASH subtraction technique. Radiology 1994; 193: 777-781.
19. Verstraete KL, De Deene Y, Roels H, Dierick A, Uttendaele D, Kunnen M. Benign and malignant musculoskeletal lesions: dynamic contrast-enhanced MR imaging - parametric "first-pass" images depict tissue vascularization and perfusion. Radiology 1994; 192:835-843.
20. Barentsz JO, van Erning LJTO, Ruijs JHJ, Bors WG, Jager G, Oosterhof G. Dynamic TurboFLASH subtraction MR imaging: perfusion of pelvic tumors (abstr). Radiology 1992; 185(P):340.
21. Harmer HM, ed. TNM classification of malignant tumors. 3rd ed. Geneva, Switzerland: Union Internaltionale Contre le Cancer, 1978.
22. Barentsz JO, Jager GJ, Mugler III JP, et al. Staging urinary bladder cancer: value of T1-weighted 3D MP-RAGE and 2D SE sequences. AJR 1995; 164:109-115.
23. Vaupel PW. Blood flow, oxygenation, tissue pH distribution and bioenergetic status of tumors. Berlin, Germany: Hellmich, 1994.
24. Dickinson AJ, Fox SB, Persad RA, Hollyer J, Sibley GNA, Harris AL. Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. Br J Urol 1994; 74:762-766.
25. Frouge C, Guinebretiere JM, Contesso G, Di Paola R, Blery M. Correlation between contrast enhancement in MR imaging of the breast and tumor angiogenesis. Invest Radiol 1994; 29:1043-1049.
26. Tanimoto A, Yuasa Y, Imai Y, et al. Bladder tumor staging: comparison of conventional and gadolinium-enhanced dynamic MR imaging and CT. Radiology 1992; 185: 741-747.
27. Barentsz JO, Boetes C, Verstraete KL, lager GJ, Mus RDM, Ruijs SHJ. Dynamic gadolinium-enhanced MR imaging of the body. Clin MR Imaging 1995; 3:88-93.
28. Husband J, Robinson I., Thomas G. Contrast enhancing lymph nodes in bladder cancer: a potential pitfall on CT. Clin Radiol 1992; 45:395-398.